当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析 - 现金流量表

亚宝药业

(600351)

  

流通市值:47.25亿  总市值:47.25亿
流通股本:7.00亿   总股本:7.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,129,022,660.04516,562,193.192,492,397,912.061,843,912,974.92
  收到的税费返还583,589.32547,328.772,490,160.31,913,119.99
  收到其他与经营活动有关的现金65,433,405.3538,896,430.7992,124,130.8953,721,610.6
  经营活动现金流入小计1,195,039,654.71556,005,952.752,587,012,203.251,899,547,705.51
  购买商品、接受劳务支付的现金311,243,959.25145,026,495.41722,482,479.63496,281,486.06
  支付给职工以及为职工支付的现金222,811,731.74115,493,585.23473,276,788.59359,233,970.97
  支付的各项税费113,156,905.2748,948,776.86289,222,439.78209,673,644.96
  支付其他与经营活动有关的现金220,528,164.25102,138,566.8630,335,922.43451,938,253.84
  经营活动现金流出小计867,740,760.51411,607,424.32,115,317,630.431,517,127,355.83
  经营活动产生的现金流量净额327,298,894.2144,398,528.45471,694,572.82382,420,349.68
二、投资活动产生的现金流量:
  收回投资收到的现金10,281,476.485,089,553.8921,425,839.334,870,239.22
  取得投资收益收到的现金544,865.42-2,475,445.771,153,967.74
  处置固定资产、无形资产和其他长期资产收回的现金净额188,076.85101,400903,324.42884,781.2
  投资活动现金流入小计11,014,418.755,190,953.8924,804,609.526,908,988.16
  购建固定资产、无形资产和其他长期资产支付的现金31,185,757.2515,255,253.2534,661,989.7428,321,521.66
  投资支付的现金24,246,600.9616,792,475.8723,789,822.8317,378,273.65
  取得子公司及其他营业单位支付的现金--5,0005,000
  投资活动现金流出小计55,432,358.2132,047,729.1258,456,812.5745,704,795.31
  投资活动产生的现金流量净额-44,417,939.46-26,856,775.23-33,652,203.05-38,795,807.15
三、筹资活动产生的现金流量:
  取得借款收到的现金140,000,00090,000,00090,000,00090,000,000
  收到其他与筹资活动有关的现金--43,742,947.9643,742,947.96
  筹资活动现金流入小计140,000,00090,000,000133,742,947.96133,742,947.96
  偿还债务支付的现金90,000,00090,000,000202,000,000202,000,000
  分配股利、利润或偿付利息支付的现金209,559,835.62616,375113,565,124.57112,783,859.84
  支付其他与筹资活动有关的现金60,670,612.4259,970,083.42243,444,339.36177,039,945.95
  筹资活动现金流出小计360,230,448.04150,586,458.42559,009,463.93491,823,805.79
  筹资活动产生的现金流量净额-220,230,448.04-60,586,458.42-425,266,515.97-358,080,857.83
四、汇率变动对现金及现金等价物的影响50,273.0441,220.918,404.6947,145.49
五、现金及现金等价物净增加额62,700,779.7456,996,515.712,794,258.49-14,409,169.81
  加:期初现金及现金等价物余额578,258,001.1578,258,001.1565,463,742.61565,463,742.61
  期末现金及现金等价物余额640,958,780.84635,254,516.8578,258,001.1551,054,572.8
补充资料:
  净利润175,188,416.73-223,915,500.69-
  资产减值准备10,010,853.29-42,162,919.81-
  固定资产和投资性房地产折旧60,600,270.96-123,986,985.53-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧60,600,270.96-123,986,985.53-
  无形资产摊销5,948,709.36-12,356,240.31-
  长期待摊费用摊销286,804.8-579,112.86-
  处置固定资产、无形资产和其他长期资产的损失-50,194.26--347,086.9-
  固定资产报废损失-16,491.61-3,441,210.31-
  公允价值变动损失-419,744.99-2,847,479.62-
  财务费用1,168,645.37-5,928,731.15-
  投资损失-992,783.8-188,362.77-
  递延所得税1,022,216.45--10,723,715.64-
  其中:递延所得税资产减少1,367,098.32--10,465,396.81-
    递延所得税负债增加-344,881.87--258,318.83-
  存货的减少49,586,821.67-11,003,212.84-
  经营性应收项目的减少63,764,586.72-93,269,142.31-
  经营性应付项目的增加-33,038,387.27--36,195,344.46-
  不涉及现金收支的投资和筹资活动金额其他项目--4,269,285.28-
  现金的期末余额640,958,780.84-578,258,001.1-
  减:现金的期初余额578,258,001.1-565,463,742.61-
  现金及现金等价物的净增加额62,700,779.74-12,794,258.49-
公告日期2025-08-162025-04-262025-04-262024-10-25
审计意见(境内)标准无保留意见
TOP↑